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Background: The diagnosis of lymphatic filariasis (LF) is based typically on either microfilaraemia as assessed by
microscopy or filarial antigenaemia using an immuno-chromatographic test. While it is known that estimates of
antigenaemia are generally higher than estimates of microfilaraemia, the extent of the difference is not known.
Methods: This paper presents the results of an extensive literature search for surveys that estimated both micro-
filaraemia and antigenaemia in order to better understand the disparity between the two measures.
Results and Conclusions: In some settings there was a very large disparity, up to 40–70%, between estimates of
microfilaraemia and antigenaemia. Regression analysis was unable to identify any predictable relationship
between the two measures. The implications of findings for risk mapping and surveillance of LF are discussed.
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Introduction
The control and elimination of lymphatic filariasis (LF), a disfigur-
ing and disabling mosquito-borne disease,1 necessitates a
detailed understanding of the geographical distribution of infec-
tion. Mapping of LF has been completed in nearly all endemic
countries and many countries are now undertaking transmission
assessment surveys (TAS) in order to determine whether mass
drug administration (MDA) can be stopped. Reliable diagnosis is
an essential prerequisite for mapping, TAS and post-MDA surveil-
lance. In the past, diagnosis was principally based on the use of
blood films collected during night blood surveys to detect the
presence of microfilariae (mf) by expert microscopy.2 The devel-
opment, in the 1990s, of a simple and rapid antigen detection
test for Wuchereria bancrofti antigenaemia, based on the
immuno-chromatographic test (ICT), revolutionized LF surveys
since it avoided the need for night blood surveys and time-
consuming microscopy.3 It is well-known that estimates of anti-
genaemia are typically higher than estimates ofmicrofilariae for a
number of biological and practical reasons, including the fact that
antifilarial drugs are highly effective againstmicrofilariae but have
minimal effect on adult worms.4 What is less clear is the extent of
the disparity in estimates and whether prevalence of antigenae-
mia can be used to predict the mf prevalence, and vice versa. To
investigate these issues, we analyzed the relationship between
prevalence of LF based on antigenaemia using ICTand microfilar-
aemia using microscopy. The implications for risk mapping and
surveillance of LF are discussed.
Materials and methods
An exhaustive literature search was made to identify prevalence
surveys where microfilaraemia and antigenaemia were assessed
among the study population. The search included surveys accord-
ing to previously defined inclusion and exclusion criteria.5 Studies
were stratified based on whether they were conducted before the
initiation of large-scale MDA (pre-intervention) or once MDA had
been initiated, as part of monitoring activities (post-intervention).
Studies were additionally stratified by continent in order to cap-
ture differences in mosquito species distribution and socio-
economic conditions, type of ICT test (i.e., AMRAD vs Binax), and
type of blood collected (venous blood vs peripheral blood). We
assumed that Binax ICT was used in surveys conducted from
2001 when the type of ICT card test was not provided (n¼74
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surveys). In all identified surveys, mf diagnosis was based on night
blood sampling. The relationship between the prevalence of
microfilaraemia (pmf) and antigenaemia (pICT) was fitted with
logistic regression as follows:
for each survey i = 1, . . . ,N,
Ymfi | pmfi  Binomial (Nmfi , pmfi )
logit(pMfi ) = a+ a1logit (pICTi ) + a2logit (pICTi )2 + aPRE × PREi
+ a1PRElogit (pICTi ) × PREi + a2PRElogit (pICTi )2 × PREi
+ aAMERICAS × AMERICASi + aASIA × ASIAi
+ aOCEANIA × OCEANIAi + aTYPECIT × TYPECITi
+ aVENOUSBLOOD × VENOUSBLOODi,
where Ymfi andNmfi denote the number of positive individuals and
the total number of individuals tested by parasitological techni-
ques (either the thick smear or filtration method), respectively.
pICTi is the prevalence estimated using the ICT and PREi is a binary
variable that is equal to 1 if the observation corresponds to a
survey conducted in pre-control settings and 0 to post-control set-
tings. AMERICASi, ASIAi and OCEANIAi e binary variables that are
equal to 1 if the observation corresponds to the Americas, Asia
or Southwest Pacific regions, respectively and 0 otherwise.
VENOUSBLOODi is equal to 1 if the blood sample was collected
on venous blood (n¼41) and 0 if collected on peripheral (i.e., finger
prick) blood (n¼215). Variation in the type of ICT used in surveys
was captured through the covariate TYPEICTi, which is 1 for
AMRAD ICT-based surveys (n¼37) and 0 for surveys using the
Binax test (n¼218). We also fitted a model including random
effects ui  N (0, s2) taking into account the variability not
explained by the covariates. The deviance information criterion
(DIC) was used to compare fittedmodels and eventually to deter-
mine model selection (i.e., model that yields the lowest DIC value
was chosen).
Results and Discussion
The literature search identified 264 surveys, including 86 surveys
conducted prior to the implementation of MDA and 178 post-MDA
Figure 1. (A) The relationship between the prevalence of lymphatic filariasis based on microfilaraemia (pmf) and prevalence estimated from
antigenemia (pICT), grouped by continent and pre- and post-control. (B) Observed and predicted relationship between pICT and pmf. For each pICT
value, observed and predicted pmf values obtained from the model without random effects grouped by pre- and post-control. Details of included
studies are shown in Supplementary Table 1.
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surveys. Details of included studies are shown in Supplementary
Table 1. In the majority (215/264) of studies mf was determined
by thick smear using between 20 and 60 ml of blood; 36 studies
used filtration techniques (using 1 to 3 ml blood). Four studies
used both thick smear and filtration methods, with estimates
obtained by filtration considered. None of the included surveys
were conducted in areas where loiasis occurs or in areas where
mass treatment against onchocerciasis had been implemented.
Figure 1A presents the relationship between pmf and pICT,
stratified by pre- and post-intervention settings and by continent,
and shows that pICT consistently overestimates prevalence com-
pared to pmf, especially in post-control settings. The correlation
between pmf and pICT is positive, but not very strong (Spearman’s
correlation coefficient of 0.62 and 0.59 under pre- and post-
intervention settings, respectively). Despite these correlations,
we were unable to obtain a well-fitting regression model between
pICT and pmf that would enable prediction of pmf from pICT
(Figure 1B). DIC values for the fitted models were 1163 and
2960 with and without random effects, respectively, indicating
that effects of unmeasured characteristics that affect all indivi-
duals surveyed contribute to the observed variability. We were
unable to account for age group, as surveys typically targeted
all age groups (n¼229/264). Sensitivity analysis explored separate
models for different volumes of blood examined (20 ml or
20–60 ml), but showed that overall model fit did not improve
(see results in the Supplementary information).
Our analysis highlights a disparity in prevalence estimates of
microfilaraemia, based on blood smears, and of antigenaemia
based on use of an ICT test. This result was to be expected as fil-
arial antigen tests detect circulating antigen of worm adults and
in pre-intervention settings, antigenaemia in children can develop
up to 2-3 years before the appearance of microfilaraemia.6
Among treated populations, adult worms retain the capacity to
resume production of microfilariae and rates of antigenaemia
are known to declinemore slowly following treatment.4 Other fac-
tors related to MDA delivery, including treatment coverage, time
interval between rounds and number of rounds, may also influ-
ence differently observed levels of microfilaraemia and antige-
naemia. In addition, the timing of night blood collection may
introduce variation in the estimates of mf prevalence since the
density of circulating mf fluctuates overnight,7 but unfortunately
few studies report this information.We recognize that our analysis
lacked a gold standard of true LF infection and that technical and
human factors may have influenced the reliability of both micro-
scopy and ICTs,2 but the results clearly show that estimates of
microfilaraemia and antigenaemia do not correspond in a predict-
able manner, especially in post-intervention settings. What was
particularly surprising in our analysis was the large difference,
up to 40–70%, in estimates of microfilaraemia and antigenaemia.
This finding has a number of practical and scientific implications.
First,WHO recommends that MDA is initiated in settingswhere the
prevalence of LF.1%andwhether this is based on pmf (as initially
recommended) or pICT (as currently recommended) may result in
different treatment decisions. Second, the lack of a predictable
relationship between microfilaraemia and antigenaemia means
that they cannot be combined in studies that seek to develop
risk maps of LF and future work should give careful consideration
to the diagnostic method when predicting the spatial distribution
of LF transmission.
Supplementary data
Supplementary data are available at Transactions Online
(http://trstmh.oxfordjournals.org/).
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